Whit Mayo
Stock Analyst at Leerink Partners
(3.18)
# 2,120
Out of 5,182 analysts
160
Total ratings
53.92%
Success rate
10.57%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $345 → $400 | $354.69 | +12.77% | 13 | Apr 22, 2026 | |
| ARDT Ardent Health | Maintains: Outperform | $16 → $15 | $10.04 | +49.40% | 3 | Mar 6, 2026 | |
| CLOV Clover Health Investments | Maintains: Market Perform | $3 → $2.5 | $2.52 | -0.79% | 5 | Mar 5, 2026 | |
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $13.08 | -8.26% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $28.15 | -21.85% | 12 | Feb 26, 2026 | |
| EHAB Enhabit | Maintains: Market Perform | $9.5 → $14 | $13.74 | +0.44% | 3 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $185.53 | +42.30% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $23.39 | -27.32% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $356.13 | -12.95% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $2.45 | +2.04% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $400 → $250 | $223.62 | +11.80% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $100.92 | -0.91% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $48.57 | -69.12% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $179.51 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $154.02 | -37.02% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $282.58 | +18.55% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $445.77 | -35.84% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $14.54 | +175.10% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $24.41 | +59.77% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $825 → $750 | $25.32 | +2,862.09% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $76.14 | +129.84% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $20.95 | -9.31% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.81 | +42.35% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $263.43 | -22.94% | 2 | May 1, 2018 |
UnitedHealth Group
Apr 22, 2026
Maintains: Outperform
Price Target: $345 → $400
Current: $354.69
Upside: +12.77%
Ardent Health
Mar 6, 2026
Maintains: Outperform
Price Target: $16 → $15
Current: $10.04
Upside: +49.40%
Clover Health Investments
Mar 5, 2026
Maintains: Market Perform
Price Target: $3 → $2.5
Current: $2.52
Upside: -0.79%
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $13.08
Upside: -8.26%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $28.15
Upside: -21.85%
Enhabit
Feb 23, 2026
Maintains: Market Perform
Price Target: $9.5 → $14
Current: $13.74
Upside: +0.44%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $185.53
Upside: +42.30%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $23.39
Upside: -27.32%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $356.13
Upside: -12.95%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $2.45
Upside: +2.04%
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $223.62
Upside: +11.80%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $100.92
Upside: -0.91%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $48.57
Upside: -69.12%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $179.51
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $154.02
Upside: -37.02%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $282.58
Upside: +18.55%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $445.77
Upside: -35.84%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $14.54
Upside: +175.10%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $24.41
Upside: +59.77%
Nov 4, 2022
Maintains: Outperform
Price Target: $825 → $750
Current: $25.32
Upside: +2,862.09%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $76.14
Upside: +129.84%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $20.95
Upside: -9.31%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.81
Upside: +42.35%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $263.43
Upside: -22.94%